Prostatic Neoplasm: Clinical Trials

3 trials for Prostatic Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 3

Follow Prostatic Neoplasm: new trials by email Literature Review of Prostatic Neoplasm trials Research Report on Prostatic Neoplasm

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RP
salvage SBRT - Prostatic Neoplasm
Phase 2UnknownRegina Elena Cancer Institute1032022-09-272022-12-28
HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer
Real time High-Dose-Rate prostate brachytherapy in combination with stereotactic prostate radiotherapy - Prostatic Neoplasm
Phase 2UnknownDavid Büchser502019-07-012020-08-24
An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma
Docetaxel, Androgen-Deprivation Therapy (ADT) - Prostatic Neoplasm
Phase 2UnknownSamsung Medical Center422017-02-082022-03-08

Narrower conditions

Prostatic Neoplasms (3)

Broader conditions

Genital Diseases (3)  ·  Genital Diseases, Male (3)  ·  Genital Neoplasms, Male (3)  ·  Male Urogenital Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Prostatic Diseases (3)  ·  Urogenital Diseases (3)  ·  Urogenital Neoplasms (3)

Interventions

Androgen Antagonists (1)  ·  Docetaxel (1)

Sponsors

David Büchser (1)  ·  Regina Elena Cancer Institute (1)  ·  Samsung Medical Center (1)

Countries

Italy (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Alfonso Gomez-Iturriaga, MD, PhD (1)